Home
>
US Stocks
>
Chimerix Inc
Chimerix Inc
CMRX

Chimerix Inc

$5.8811.18%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.83
Today Low/High
5.83 / 5.88
52 Week Low/High
$2.22 / $11.57
P/E ratio
-3.9237
Market Cap
$542.51M

Company Details

Chimerix is a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases. The company's three most advanced clinical-stage development programs are BCV, ONC201 and DSTAT. BCV is an antiviral drug candidate developed as a potential medical countermeasure for smallpox and is currently under review for regulatory approval in the United States. ONC201 is currently in a registrational clinical program for recurrent H3 K27M-mutant glioma and a confirmatory response rate assessment is expected later this year. DSTAT is in development as a potential first-line therapy in acute myeloid leukemia and as a potential treatment for acute lung injury in hospitalized COVID-19 patients.
Organisation
Chimerix Inc
Headquaters
Durham, North Carolina, US
Employees
54
Industry
Health Technology
CEO
Michael Sherman

Discover more

Frequently Asked Questions

What is Chimerix Inc share price today

Can Indians buy Chimerix Inc shares?

How can I buy Chimerix Inc shares from India?

Can Fractional shares of Chimerix Inc be purchased?

What are the documents required to start investing in Chimerix Inc stocks?

We are a SEBI registered investement advisor